FR2736358B1 - RECOMBINANT MYXOMATOUS VIRUS - Google Patents

RECOMBINANT MYXOMATOUS VIRUS

Info

Publication number: FR2736358B1
Authority: FR; France
Prior art keywords: myxomatous; recombinant; virus; recombinant myxomatous; myxomatous virus
Prior art date: 1995-07-05
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

FR9508128A

Other languages

French (fr)

Other versions

FR2736358A1 (en

Inventor

Stephane Bertagnoli

Jacqueline Gelfi

Baralon Corine Boucraut

Frederique Petit

Alain Milon

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Institut National de la Recherche Agronomique INRA

Original Assignee

Institut National de la Recherche Agronomique INRA

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-07-05

Filing date

1995-07-05

Publication date

1997-09-26

1995-07-05 Application filed by Institut National de la Recherche Agronomique INRA filed Critical Institut National de la Recherche Agronomique INRA

1995-07-05 Priority to FR9508128A priority Critical patent/FR2736358B1/en

1996-07-05 Priority to DE19627193A priority patent/DE19627193B4/en

1996-07-05 Priority to IT96TO000578A priority patent/IT1286307B1/en

1996-07-05 Priority to ES09601551A priority patent/ES2113322B1/en

1997-01-10 Publication of FR2736358A1 publication Critical patent/FR2736358A1/en

1997-09-26 Application granted granted Critical

1997-09-26 Publication of FR2736358B1 publication Critical patent/FR2736358B1/en

2011-11-15 Priority to FR11C0050C priority patent/FR11C0050I2/en

2015-07-05 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/275—Poxviridae, e.g. avipoxvirus
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
- A61K2039/541—Mucosal route
- A61K2039/542—Mucosal route oral/gastrointestinal
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/70—Multivalent vaccine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/24011—Poxviridae
- C12N2710/24041—Use of virus, viral particle or viral elements as a vector
- C12N2710/24043—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/16011—Caliciviridae
- C12N2770/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Virology (AREA)
Genetics & Genomics (AREA)
General Health & Medical Sciences (AREA)
Microbiology (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Mycology (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
Biophysics (AREA)
Bioinformatics & Cheminformatics (AREA)
Biochemistry (AREA)
Physics & Mathematics (AREA)
Plant Pathology (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

FR9508128A 1995-07-05 1995-07-05 RECOMBINANT MYXOMATOUS VIRUS Expired - Lifetime FR2736358B1 (en)

Priority Applications (5)

Application Number	Priority Date	Filing Date	Title
FR9508128A FR2736358B1 (en)	1995-07-05	1995-07-05	RECOMBINANT MYXOMATOUS VIRUS
DE19627193A DE19627193B4 (en)	1995-07-05	1996-07-05	Recombinant myxomatic virus
IT96TO000578A IT1286307B1 (en)	1995-07-05	1996-07-05	RECOMBINANT MYXOMATOUS VIRUS, ITS USE FOR THE PRODUCTION OF A VACCINE AND RELATED VACCINE.
ES09601551A ES2113322B1 (en)	1995-07-05	1996-07-05	RECOMBINANT MIXOMATOUS VIRUSES.
FR11C0050C FR11C0050I2 (en)	1995-07-05	2011-11-15	RECOMBINANT MYXOMATOUS VIRUS

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9508128A FR2736358B1 (en)	1995-07-05	1995-07-05	RECOMBINANT MYXOMATOUS VIRUS

Publications (2)

Publication Number	Publication Date
FR2736358A1 FR2736358A1 (en)	1997-01-10
FR2736358B1 true FR2736358B1 (en)	1997-09-26

Family

ID=9480712

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
FR9508128A Expired - Lifetime FR2736358B1 (en)	1995-07-05	1995-07-05	RECOMBINANT MYXOMATOUS VIRUS
FR11C0050C Active FR11C0050I2 (en)	1995-07-05	2011-11-15	RECOMBINANT MYXOMATOUS VIRUS

Family Applications After (1)

Application Number	Title	Priority Date	Filing Date
FR11C0050C Active FR11C0050I2 (en)	1995-07-05	2011-11-15	RECOMBINANT MYXOMATOUS VIRUS

Country Status (4)

Country	Link
DE (1)	DE19627193B4 (en)
ES (1)	ES2113322B1 (en)
FR (2)	FR2736358B1 (en)
IT (1)	IT1286307B1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2153284B1 (en) *	1998-06-10	2001-09-01	Fundacion Para El Estudio Y De	NEW RECOMBINANT VIRUS OF ATTENATED MIXOMA AND ITS USE IN THE PREPARATION OF MIXED VACCINES AGAINST MIXOMATOSIS AND HEMORRAGICAL DISEASE OF THE RABBITS.
DK1370668T3 (en)	2001-03-08	2006-06-06	Akzo Nobel Nv	Leporipox-based vector vaccines
FR2946536B1 (en) *	2009-06-11	2011-07-29	Agronomique Inst Nat Rech	USE OF AN ATXURATED STRAIN OF MYXOMA VIRUS AS AN ONCOLYTIC
WO2017037523A1 (en)	2015-06-19	2017-03-09	Sillajen, Inc.	Compositions and methods for viral embolization

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5869312A (en) *	1992-01-13	1999-02-09	Syntro Corporation	Recombinant swinepox virus

1995
- 1995-07-05 FR FR9508128A patent/FR2736358B1/en not_active Expired - Lifetime
1996
- 1996-07-05 IT IT96TO000578A patent/IT1286307B1/en active IP Right Grant
- 1996-07-05 ES ES09601551A patent/ES2113322B1/en not_active Expired - Fee Related
- 1996-07-05 DE DE19627193A patent/DE19627193B4/en not_active Expired - Lifetime
2011
- 2011-11-15 FR FR11C0050C patent/FR11C0050I2/en active Active

Also Published As

Publication number	Publication date
FR11C0050I1 (en)	2011-12-16
DE19627193A1 (en)	1997-03-20
FR11C0050I2 (en)	2012-06-22
ITTO960578A0 (en)	1996-07-05
ES2113322A1 (en)	1998-04-16
DE19627193B4 (en)	2007-08-30
IT1286307B1 (en)	1998-07-08
ITTO960578A1 (en)	1998-01-05
ES2113322B1 (en)	1998-12-01
FR2736358A1 (en)	1997-01-10

Publication	Publication Date	Title
NO2010013I1 (en)	2010-06-07	Recombinant FSH-CTP
DK0736303T3 (en)	2000-01-10	interferon
DK0809996T3 (en)	2003-07-21	interferon
DK0810877T3 (en)	2002-02-25	Hepatitis B vaccine
DE59604011D1 (en)	2000-02-03	oven
DE69606628D1 (en)	2000-03-16	OVEN
DE69829373D1 (en)	2005-04-21	Polymerization
NO976058L (en)	1998-02-03	Recombinant Mistakine
DE69813694D1 (en)	2003-05-28	polymerization
BR9610239A (en)	1999-06-15	Xcd32-allergen-fusion proteins
FI972030A0 (en)	1997-05-13	Purified papillomavirus proteins
FI970168A0 (en)	1997-01-15	peptides
DE69608637D1 (en)	2000-07-06	Magnetron
FR11C0050I2 (en)	2012-06-22	RECOMBINANT MYXOMATOUS VIRUS
DE69839129D1 (en)	2008-03-27	Polymerization
IS4629A (en)	1997-12-05	Linked viral nucleic acids
DE59503694D1 (en)	1998-10-29	oven
DE69826832D1 (en)	2004-11-11	Polymerization
BR9606756A (en)	1998-01-06	Peptide
SE9602868D0 (en)	1996-07-25	Oven
NO981051D0 (en)	1998-03-10	peptide
DE59601829D1 (en)	1999-06-10	OVEN
FI944558A0 (en)	1994-09-30	Virus
ITMI950511A0 (en)	1995-03-16	IMPROVED PARALLEL PHOTODENSITOMETER
DK1325957T3 (en)	2007-02-05	Recombinant papilloma virus L1

Legal Events

Date	Code	Title	Description
2011-11-15	CP	Supplementary protection certificate (spc) filed	Free format text: PRODUCT NAME: VIRUS VIVANT DE LA MYXOMATOSE EXPRIMANT UNE GLYCOPROTEINE DU VIRUS DE LA MHL, SOUCHE 009; REGISTRATION NO/DATE: EU/2/11/132/001-004 20110907 Spc suppl protection certif: 11C0050 Filing date: 20111115
2011-12-16	CP	Supplementary protection certificate (spc) filed	Free format text: PRODUCT NAME: NOBIVAC MYXO-RHD VIRUS VIVANT DE LA MYXOMATOSE EXPRIMANT UNE GLYCOPROTEINE DU VIRUS DE LA MHL, SOUCHE 009; REGISTRATION NO/DATE: EU/2/11/132/001-004 20110907 Spc suppl protection certif: 11C0050 Filing date: 20111115
2011-12-30	CP	Supplementary protection certificate (spc) filed	Effective date: 20111130
2012-05-21	CT	Granted supplementary protection certificate (spc) for medicine (eec regulation of 18 june 1992)	Free format text: PRODUCT NAME: VIRUS VIVANT DE LA MYXOMATOSE EXPRIMANT UNE GLYCOPROTEINE DU VIRUS DE LA MHL, SOUCHE 009; REGISTRATION NO/DATE: EU/2/11/132/001-004 20110907 Spc suppl protection certif: 11C0050 Filing date: 20111115 Extension date: 20200704 Effective date: 20120622
2012-06-22	AV	Other action affecting the existence or the validity of an industrial property right	Effective date: 20120524
2012-06-22	CT	Granted supplementary protection certificate (spc) for medicine (eec regulation of 18 june 1992)	Free format text: PRODUCT NAME: VIRUS VIVANT DE LA MYXOMATOSE EXPRIMANT UNE GLYCOPROTEINE DU VIRUS DE LA MHL, SOUCHE 009; REGISTRATION NO/DATE: EU/2/11/132/001 20110907 Spc suppl protection certif: 11C0050 Filing date: 20111115 Extension date: 20200704
2015-06-29	SPAY	Annual fee for spc paid [supplementary protection certificate]	Free format text: PRODUCT NAME: VIRUS VIVANT DE LA MYXOMATOSE EXPRIMANT UNE GLYCOPROTEINE DU VIRUS DE LA MHL, SOUCHE 009; REGISTRATION NO/DATE: EU/2/11/132/001-004 20110907 Spc suppl protection certif: 11C0050 Filing date: 20111115 Year of fee payment: 1 Extension date: 20200704
2016-06-17	SPAY	Annual fee for spc paid [supplementary protection certificate]	Free format text: PRODUCT NAME: VIRUS VIVANT DE LA MYXOMATOSE EXPRIMANT UNE GLYCOPROTEINE DU VIRUS DE LA MHL, SOUCHE 009; REGISTRATION NO/DATE: EU/2/11/132/001-004 20110907 Spc suppl protection certif: 11C0050 Filing date: 20111115 Year of fee payment: 2 Extension date: 20200704
2017-06-16	SPAY	Annual fee for spc paid [supplementary protection certificate]	Free format text: PRODUCT NAME: VIRUS VIVANT DE LA MYXOMATOSE EXPRIMANT UNE GLYCOPROTEINE DU VIRUS DE LA MHL, SOUCHE 009; REGISTRATION NO/DATE: EU/2/11/132/001-004 20110907 Spc suppl protection certif: 11C0050 Filing date: 20111115 Year of fee payment: 3 Extension date: 20200704
2018-06-18	SPAY	Annual fee for spc paid [supplementary protection certificate]	Free format text: PRODUCT NAME: VIRUS VIVANT DE LA MYXOMATOSE EXPRIMANT UNE GLYCOPROTEINE DU VIRUS DE LA MHL, SOUCHE 009; REGISTRATION NO/DATE: EU/2/11/132/001-004 20110907 Spc suppl protection certif: 11C0050 Filing date: 20111115 Year of fee payment: 4 Extension date: 20200704
2019-06-21	SPAY	Annual fee for spc paid [supplementary protection certificate]	Free format text: PRODUCT NAME: VIRUS VIVANT DE LA MYXOMATOSE EXPRIMANT UNE GLYCOPROTEINE DU VIRUS DE LA MHL, SOUCHE 009; REGISTRATION NO/DATE: EU/2/11/132/001-004 20110907 Spc suppl protection certif: 11C0050 Filing date: 20111115 Year of fee payment: 5 Extension date: 20200704